Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The gain of apolipoprotein E genotyping to separate patients with Alzheimer's disease from normal individuals: relevance to community studies.

Dementia (Basel, Switzerland) - 1 Jan 2000

Frisoni G B, Geroldi C, Bianchetti A, Binetti G, Trabucchi M

Abstract excerpt

Neuropsychological screening tests such as the Mini Mental State Examination (MMSE) are commonly used for case finding in community studies on dementia or Alzheimer's disease (AD). However, the high proportion of false-positives is an important limitation to the feasibility of such studies. The aim of this study was to evaluate whether adding apoliporotein E (apoE) genotyping to the MMSE is followed by a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Genotype

Share to Mass Screening

Share to Neuropsychological Tests

Share to Reference Values

Source

Identifiers

PMID: 8915040
DOI: 10.1159/000106900

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The gain of apolipoprotein E genotyping to separate patients with Alzheimer's disease from normal individuals: relevance to community studies.PMID 8915040Read ↗

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.Semantic proximity Read ↗

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.Semantic proximity Read ↗

Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease.Semantic proximity Read ↗

The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.Semantic proximity Read ↗

Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseSemantic proximity Read ↗

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.Semantic proximity Read ↗

Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.Semantic proximity Read ↗

Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.Semantic proximity Read ↗

Predictive value of APOE genotyping in incipient Alzheimer's disease.Semantic proximity Read ↗

Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.Semantic proximity Read ↗

Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.